Cargando…
Comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584072/ https://www.ncbi.nlm.nih.gov/pubmed/36259573 http://dx.doi.org/10.4103/singaporemedj.SMJ-2022-141 |
_version_ | 1784813198801633280 |
---|---|
author | Kabuli, Mahsa Akbari, Amir Reza Alam, Benyamin |
author_facet | Kabuli, Mahsa Akbari, Amir Reza Alam, Benyamin |
author_sort | Kabuli, Mahsa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9584072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-95840722022-10-21 Comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore Kabuli, Mahsa Akbari, Amir Reza Alam, Benyamin Singapore Med J Letter to the Editor Wolters Kluwer - Medknow 2022-09-30 /pmc/articles/PMC9584072/ /pubmed/36259573 http://dx.doi.org/10.4103/singaporemedj.SMJ-2022-141 Text en Copyright: © 2022 Singapore Medical Journal https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Letter to the Editor Kabuli, Mahsa Akbari, Amir Reza Alam, Benyamin Comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title | Comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title_full | Comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title_fullStr | Comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title_full_unstemmed | Comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title_short | Comments on: Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore |
title_sort | comments on: two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary asian vascular centre in singapore |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584072/ https://www.ncbi.nlm.nih.gov/pubmed/36259573 http://dx.doi.org/10.4103/singaporemedj.SMJ-2022-141 |
work_keys_str_mv | AT kabulimahsa commentsontwoyearclinicaloutcomesfollowinglowerlimbendovascularrevascularisationforchroniclimbthreateningischaemiaatatertiaryasianvascularcentreinsingapore AT akbariamirreza commentsontwoyearclinicaloutcomesfollowinglowerlimbendovascularrevascularisationforchroniclimbthreateningischaemiaatatertiaryasianvascularcentreinsingapore AT alambenyamin commentsontwoyearclinicaloutcomesfollowinglowerlimbendovascularrevascularisationforchroniclimbthreateningischaemiaatatertiaryasianvascularcentreinsingapore |